Skip to main content
. 2014 Jan 11;3:2. doi: 10.1186/2162-3619-3-2

Figure 1.

Figure 1

New agents for overcoming AR. This figure shows the parallel and downstream signaling pathways of the EGFR. The gray boxes depict new agents available for treatment.